| pubmed-article:20019991 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20019991 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
| pubmed-article:20019991 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:20019991 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:20019991 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:20019991 | lifeskim:mentions | umls-concept:C0543467 | lld:lifeskim |
| pubmed-article:20019991 | lifeskim:mentions | umls-concept:C1522484 | lld:lifeskim |
| pubmed-article:20019991 | lifeskim:mentions | umls-concept:C0036525 | lld:lifeskim |
| pubmed-article:20019991 | lifeskim:mentions | umls-concept:C1273870 | lld:lifeskim |
| pubmed-article:20019991 | pubmed:issue | 6 Suppl 4 | lld:pubmed |
| pubmed-article:20019991 | pubmed:dateCreated | 2009-12-18 | lld:pubmed |
| pubmed-article:20019991 | pubmed:abstractText | Metastatic or unresectable disease is identified in approximately 20% of patients presenting with invasive urothelial cancer. In addition, up to 50% of patients will develop metastases following radical cystectomy for clinically localized disease. Multiagent cisplatin-based chemotherapy is considered standard first-line treatment for these patients. Although urothelial cancer is considered a chemosensitive tumour, metastatic disease is associated with poor prognosis and short-term survival. Here, we review the role of a multidisciplinary approach to treating patients with metastatic urothelial cancer. | lld:pubmed |
| pubmed-article:20019991 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20019991 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20019991 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20019991 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20019991 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20019991 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20019991 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20019991 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20019991 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20019991 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20019991 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20019991 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20019991 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20019991 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20019991 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20019991 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20019991 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20019991 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20019991 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20019991 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20019991 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20019991 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20019991 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20019991 | pubmed:status | PubMed-not-MEDLINE | lld:pubmed |
| pubmed-article:20019991 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:20019991 | pubmed:issn | 1911-6470 | lld:pubmed |
| pubmed-article:20019991 | pubmed:author | pubmed-author:DinneyColin... | lld:pubmed |
| pubmed-article:20019991 | pubmed:author | pubmed-author:Siefker-Radtk... | lld:pubmed |
| pubmed-article:20019991 | pubmed:author | pubmed-author:SvatekRobert... | lld:pubmed |
| pubmed-article:20019991 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:20019991 | pubmed:volume | 3 | lld:pubmed |
| pubmed-article:20019991 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20019991 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20019991 | pubmed:pagination | S228-31 | lld:pubmed |
| pubmed-article:20019991 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:20019991 | pubmed:articleTitle | Management of metastatic urothelial cancer: the role of surgery as an adjunct to chemotherapy. | lld:pubmed |
| pubmed-article:20019991 | pubmed:affiliation | The University of Texas MD Anderson Cancer Center, Department of Urologic Oncology; | lld:pubmed |
| pubmed-article:20019991 | pubmed:publicationType | Journal Article | lld:pubmed |
